135 related articles for article (PubMed ID: 37778413)
1. MiR-206 inhibits estrogen signaling and ovarian cancer cell migration without affecting GPER.
Boscaro C; Ramaschi GE; Trevisi L; Cignarella A; Bolego C
Life Sci; 2023 Nov; 333():122135. PubMed ID: 37778413
[TBL] [Abstract][Full Text] [Related]
2. Targeting of PFKFB3 with miR-206 but not mir-26b inhibits ovarian cancer cell proliferation and migration involving FAK downregulation.
Boscaro C; Baggio C; Carotti M; Sandonà D; Trevisi L; Cignarella A; Bolego C
FASEB J; 2022 Mar; 36(3):e22140. PubMed ID: 35107852
[TBL] [Abstract][Full Text] [Related]
3. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
[TBL] [Abstract][Full Text] [Related]
4. The novel estrogen receptor GPER regulates the migration and invasion of ovarian cancer cells.
Yan Y; Liu H; Wen H; Jiang X; Cao X; Zhang G; Liu G
Mol Cell Biochem; 2013 Jun; 378(1-2):1-7. PubMed ID: 23580092
[TBL] [Abstract][Full Text] [Related]
5. The G-protein-coupled estrogen receptor, a gene co-expressed with ERα in breast tumors, is regulated by estrogen-ERα signalling in ERα positive breast cancer cells.
Pal U; Manjegowda MC; Singh N; Saikia S; Philip BS; Jyoti Kalita D; Kumar Rai A; Sarma A; Raphael V; Modi D; Chandra Kataki A; Mukund Limaye A
Gene; 2023 Aug; 877():147548. PubMed ID: 37279863
[TBL] [Abstract][Full Text] [Related]
6. The G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patients.
Heublein S; Mayr D; Vrekoussis T; Friese K; Hofmann SS; Jeschke U; Lenhard M
PLoS One; 2013; 8(8):e71791. PubMed ID: 23951246
[TBL] [Abstract][Full Text] [Related]
7. Role of GPER on proliferation, migration and invasion in ligand-independent manner in human ovarian cancer cell line SKOV3.
Yan Y; Jiang X; Zhao Y; Wen H; Liu G
Cell Biochem Funct; 2015 Dec; 33(8):552-9. PubMed ID: 26526233
[TBL] [Abstract][Full Text] [Related]
8. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
[TBL] [Abstract][Full Text] [Related]
9. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.
Li Y; Birnbaumer L; Teng CT
Mol Endocrinol; 2010 May; 24(5):969-80. PubMed ID: 20211987
[TBL] [Abstract][Full Text] [Related]
10. The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro.
Han N; Heublein S; Jeschke U; Kuhn C; Hester A; Czogalla B; Mahner S; Rottmann M; Mayr D; Schmoeckel E; Trillsch F
Cells; 2021 Mar; 10(3):. PubMed ID: 33799631
[TBL] [Abstract][Full Text] [Related]
11. Dynamic monitoring of GPER-mediated estrogenic effects in breast cancer associated fibroblasts: An alternative role of estrogen in mammary carcinoma development.
Luo H; Liu M; Luo S; Yu T; Wu C; Yang G; Tu G
Steroids; 2016 Aug; 112():1-11. PubMed ID: 27016131
[TBL] [Abstract][Full Text] [Related]
12. A novel estrogen receptor GPER mediates proliferation induced by 17β-estradiol and selective GPER agonist G-1 in estrogen receptor α (ERα)-negative ovarian cancer cells.
Liu H; Yan Y; Wen H; Jiang X; Cao X; Zhang G; Liu G
Cell Biol Int; 2014 May; 38(5):631-8. PubMed ID: 24446390
[TBL] [Abstract][Full Text] [Related]
13. Non-genomic mechanisms in the estrogen regulation of glycolytic protein levels in endothelial cells.
Boscaro C; Carotti M; Albiero M; Trenti A; Fadini GP; Trevisi L; Sandonà D; Cignarella A; Bolego C
FASEB J; 2020 Sep; 34(9):12768-12784. PubMed ID: 32757462
[TBL] [Abstract][Full Text] [Related]
14. GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer.
Tao S; He H; Chen Q; Yue W
Biochem Biophys Res Commun; 2014 Aug; 451(1):74-8. PubMed ID: 25063027
[TBL] [Abstract][Full Text] [Related]
15. Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor α (ERα).
Tsai CL; Wu HM; Lin CY; Lin YJ; Chao A; Wang TH; Hsueh S; Lai CH; Wang HS
PLoS One; 2013; 8(9):e72999. PubMed ID: 24039841
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-424 suppresses estradiol-induced cell proliferation via targeting GPER in endometrial cancer cells.
Zhang H; Wang X; Chen Z; Wang W
Cell Mol Biol (Noisy-le-grand); 2015 Nov; 61(7):96-101. PubMed ID: 26638889
[TBL] [Abstract][Full Text] [Related]
17. 17β-Estradiol and Agonism of G-protein-Coupled Estrogen Receptor Enhance Hippocampal Memory via Different Cell-Signaling Mechanisms.
Kim J; Szinte JS; Boulware MI; Frick KM
J Neurosci; 2016 Mar; 36(11):3309-21. PubMed ID: 26985039
[TBL] [Abstract][Full Text] [Related]
18. GPER-mediated proliferation and estradiol production in breast cancer-associated fibroblasts.
Luo H; Yang G; Yu T; Luo S; Wu C; Sun Y; Liu M; Tu G
Endocr Relat Cancer; 2014 Apr; 21(2):355-69. PubMed ID: 24481325
[TBL] [Abstract][Full Text] [Related]
19. Soy Isoflavones Accelerate Glial Cell Migration
Ariyani W; Miyazaki W; Amano I; Hanamura K; Shirao T; Koibuchi N
Front Endocrinol (Lausanne); 2020; 11():554941. PubMed ID: 33250856
[TBL] [Abstract][Full Text] [Related]
20. G Protein-Coupled Estrogen Receptor Correlates With Dkk2 Expression and Has Prognostic Impact in Ovarian Cancer Patients.
Fraungruber P; Kaltofen T; Heublein S; Kuhn C; Mayr D; Burges A; Mahner S; Rathert P; Jeschke U; Trillsch F
Front Endocrinol (Lausanne); 2021; 12():564002. PubMed ID: 33679613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
